[Federal Register Volume 69, Number 4 (Wednesday, January 7, 2004)]
[Notices]
[Pages 930-931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-255]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Secretary's Advisory Committee on Xenotransplantation (SACX).

[[Page 931]]

    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.

    Name of Committee: Secretary's Advisory Committee on 
Xenotransplantation.
    Date: February 24, 2004.
    Open: February 24, 2004; 8 a.m. to 5:30 p.m.
    Agenda: The SACX will focus on a variety of issues relating to 
the science and ethics of xenotransplantation. A significant portion 
of the meeting will be devoted to discussion of two draft reports by 
the SACX. These draft reports address the state of the science in 
xenotransplantation and informed consent issues in 
xenotransplantation. Additional presentations and discussion will 
focus on recent advances in xenotransplantation research, including 
a report of a clinical study of porcine islet xenotransplantation in 
type 1 diabetic patients.
    Place: Holiday Inn Select, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Pre-Registration: The SACX meeting is open to the public; 
however, seating is limited and pre-registration is encouraged. To 
register, please contact Capital Consulting Corporation (Terry 
Fisher) at 301-468-6004, extension 434. Individuals who plan to 
attend the meeting and who need special assistance or other 
reasonable accommodations should notify Ms. Fisher prior to the 
meeting.
    Public Comment: Individuals who wish to provide public comment 
(oral or written) should contact the SACX Executive Director, Dr. 
Mary Groesch, by telephone at 301-496-0785 or e-mail at 
[email protected].
    Contact Person: Mary Groesch, Ph.D., Executive Director, 
Secretary's Advisory Committee on Xenotransplantation, Office of 
Science Policy, Rockledge I, Room 750, Bethesda, MD 20892, 301-496-
9838.
    Information is also available on the Office's home page: http://www4.od.nih.gov/oba/Sacx.htm, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)


    Dated: December 31, 2003.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-255 Filed 1-6-04; 8:45 am]
BILLING CODE 4140-01-M